| Market Size 2023 (Base Year) | USD 47.23 Billion |
| Market Size 2032 (Forecast Year) | USD 71.53 Billion |
| CAGR | 4.72% |
| Forecast Period | 2024 - 2032 |
| Historical Period | 2018 - 2022 |
According to Market Research Store, the global Home infusion therapy Market was worth USD 47.23 Billion in 2023. The market is forecast to reach USD 71.53 Billion by 2032, growing at a compound annual growth rate (CAGR) of 4.72% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Home infusion therapy Market industry over the next decade.

To Get more Insights, Request a Free Sample
Infusion therapy involves the administration of drug intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Technological advances have enabled safe and effective administration of infusion therapies at home. Infusion therapy is required in several health conditions which include infections that are not responsive to oral antibiotics, cancer-related pain, dehydration, gastrointestinal disorders and much more. For individuals requiring long-term therapy, inpatient care is needed Home infusion has been proven to be a safe and effective alternative.
Global home infusion therapy market is primarily driven by growing aging population and prevalence of chronic diseases such as cancer, obesity, diabetes, asthma, and other life-threatening conditions. In addition to this, the adoption of home infusion therapy products as well as services in underdeveloped and developed regions has augmented due to cost-effective treatments in the past few years, thereby fueling growth of the market
Nonetheless, rising preference for homecare facilities is likely to disclose the new avenues for home infusion therapy market in the near future.

To Get more Insights, Request a Free Sample
| Report Attributes | Report Details |
|---|---|
| Report Name | Home infusion therapy Market |
| Market Size in 2023 | USD 47.23 Billion |
| Market Forecast in 2032 | USD 71.53 Billion |
| Growth Rate | CAGR of 4.72% |
| Number of Pages | 155 |
| Key Companies Covered | Baxter, B. Braun Melsungen AG, Care Fusion Corporation, ICU Medical, Inc., Fresenius Kabi AG, JMS Co. Ltd., Terumo Corporation, Smiths Medical and Caesarea Medical Electronics among others. |
| Segments Covered | By Products, By Application Types and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Segment Analysis Preview
Based on Product type, the market can be segmented into the infusion pump, intravenous sets, IV cannulas and needleless connectors. Infusion pump was the major segment and it accounted the major share of total revenue generated in 2020. Needleless connectors are fastest growing segments in this market.
On the basis of application type, the market is divided into anti-infectives, endocrinology, enteral nutrition, hydration therapy, chemotherapy, parenteral infusion, immunoglobulin infusion and others. Anti-infectives was the major segment and it accounted for over maximum share of total revenue generated in 2023. Enteral nutrition, parenteral infusion, and chemotherapy were the fastest growing segments in this market.
The global home infusion therapy market by North America and it held a maximum share of total revenue generated in 2023. This growth can be attributed to the presence of key players and good health awareness among people. The growth is also due to a large number of chronic diseases and growing geriatric population in this region. There is a significant increase in IV based therapy drugs to treat chronic and rare diseases (including blood factors, corticosteroids, growth hormones, immunoglobulin, monoclonal therapies and others) are being infused in home settings. There is a rise in adoption of home infusion therapy in the administration of anti-infectives such as antibiotics, antiviral, antifungal drugs, chemotherapy drugs, parenteral nutrition, hydration products and pain management.
Europe is another leading regional market followed by North America on account of advanced medical facilities and growing number of specialty-pharmacy and home-infusion centers in European countries. The region has a lot to offer, as the population is more health conscious and faster adoption rate of home infusion therapy due to rise in per capita income. Asia Pacific was a fastest growing market on account of rising geriatric population, rising disposable income and increasing consumer spending towards healthcare. The region is fastest developing owing to raising awareness among people regarding the use of infusion drug therapies in hospitals and healthcare facilities. Latin America was emerging market with rising healthcare infrastructure. Brazil and rest of Latin America are anticipated to fuel the market growth in coming years.

To Get more Insights, Request a Free Sample
Some of the major players of the global home infusion therapy market include

To Get more Insights, Request a Free Sample
By Products
By Application Types
By Region
Home infusion therapy
Home infusion therapy
×